| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |